Molecular cloning, chromosomal mapping, and developmental expression of a novel protein tyrosine phosphatase-like gene

Genomics

Volumn 62, Issue 3, 1999, Pages 406-416

  Uwanogho, Dafe A ^a   Hardcastle, Zoë ^a   Balogh, Piroska ^b   Mirza, Ghazala ^a   Thornburg, Kent L ^b   Ragoussis, Jiannis ^a   Sharpe, Raul T ^a  

^a GUY S HOSPITAL   (United Kingdom)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; PROTEIN TYROSINE PHOSPHATASE;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CHROMOSOMAL LOCALIZATION; DEVELOPMENTAL GENETICS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALIA; MAMMALIA;

EID: 0033572261     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1999.5950     Document Type: Article

References (62)

1. Altura, R. A., Maris, J. M., Li, H., Boyett, J. M., Brodeur, G. M., and Look, A. T. (1997). Novel regions of chromosomal loss in familial neuroblastoma by comparative genomic hybridization. Genes Chromosomes Cancer 19(3): 176-184.
2. Anderson, J. J., Tiniakos, D. G., McIntosh, G. G., Autzen, P., Henry, J. A., Thomas, M. D., Reed, J., Horne, G. M., Lennard, T. W., Angus, B., and Home, C. H. (1996). Retinoblastoma protein in human breast carcinoma: Immunohistochemical study using a new monoclonal antibody effective on routinely used tissues. J. Pathol. 180: 65-70.
3. Angerer, L. M., and Angerer, R. C. (1991). Localization of mRNAs by in situ hybridization. Methods Cell. Biol. 35: 37-71.
4. Bairoch, A., Bucher, P., and Hofmann, K. (1996). The PROSITE database, its status in 1995. Nucleic Acids Res. 24: 189-196.
5. Barnea, G., Silvennoinen, O., Shaanan, B., Honegger, A. M., Canoll, P. D., D'Eustachio, P., Morse, B., Levy, J. B., Laforgia, S., Huebner, K., et al. (1993). Identification of a carbonic anhydrase-like domain in the extracellular region of RPTP gamma defines a new subfamily of receptor tyrosine phosphatases. Mol. Cell. Biol. 13: 1497-1506.
6. Bernards, R., Schackleford, G. M., Gerber, M. R., Horowitz, J. M., Friend, S. H., Schartl, M., Bogenmann, E., Rapaport, J. M., McGee, T., Dryja, T. P., et al. (1989). Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl. Acad. Sci. USA 86: 6474-6478.
7. Boulikas, T. (1994). Putative nuclear localization signals (NLS) in protein transcription factors. J. Cell. Biochem. 55: 32-58.
8. Cavener, D. (1987). Comparison of the consesus sequence flanking translation start sites in Drosophila and vertebrates. Nucleic Acids Res. 15: 1353-1361.
9. Challice, C. E., and Viragh, S. (1974). The architectural development of the early mammalian heart. Tissue Cell 6: 447-462.
10. Chen, G., Guy, C. T., Chen, H. W., Hu, N., Lee, E. Y., and Lee W. H. (1996). Molecular cloning and developmental expression of mouse p130, a member of the retinoblastoma gene family. J. Biol. Chem. 271: 9567-9572.
11. Cho, H. J., Ramer, S. E., Itoh, M., Winkler, D. G., Kitas, E., Bannwarth, W., Burn, P., Saito, H., and Walsh, C. T. (1992). Purification and characterization of a soluble catalytic fragment of the human transmembrane leukocyte antigen related (LAR) protein tyrosine phosphatase from an Escherichia coli expression system. Biochemistry 30: 6210-6216.
12. Cohen, P. (1994). The discovery of protein phosphatases: From chaos and confusion to an understanding of their role in cell regulation and human disease. BioEssays 16: 583-585.
13. Coleman, T. R., and Dunphy, W. G. (1994). Cdc2 regulatory factors. Curr. Opin. Cell. Biol. 6: 877-882.
14. Coriat, A.-M., Müller, U., Harry, J. L., Uwanogho, D., Sharpe, P. T. (1993). PCR amplification of SRY-related gene sequences reveals evolutionary conservation of the SRY-box motif. PCR Methods Appl. 2: 218-222.
15. Dasouki, M., Jurecic, V., Phillips, J. A. R., Whitlock, J. A., and Baldini, A. (1997). DiGeorge anomaly and chromosome 10p deletions: One or two loci. Am. J. Med. Genet. 73: 72-75.
16. Davies, A. F., Olavesen, M. G., Stephens, R. J., Davidson, R., Delneste, D., Van Regemorter, N., Vamos, E., Flinter, F., Abusaad, I., and Ragoussis, J. (1996). A detailed investigation of two cases exhibiting characteristics of the 6p deletion syndrome. Hum. Genet. 98: 454-459.
17. Daw, S. C., Taylor, C., Kraman, M., Call, K., Mao, J., Schuffenhauer, S., Metinger, T., Lipson, T., Goodship, J., and Scambler, P. (1996). A common region of 10p deleted in DiGeorge and velocardiofacial syndromes. Nat. Genet. 13: 458-460.
18. Denu, J. M., Zhou, G., Guo, Y., Dixon, J. E. (1995). The catalytic role of aspartic acid-92 in a human dual-specific protein-tyrosine-phosphatase. Biochemistry 34: 3396-3403.
19. Denu, J. M., Lohse, D. L., Vijayalakshmi, J., Saper, M. A., and Dixon, J. E. (1996). Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis. Proc. Natl. Acad. Sci. USA 93: 2493-2498.
20. De Vivo, I., Cui, X., Domen, J., and Cleary, M. L. (1998). Growth stimulation of primary B cell precursors by the anti-phosphatase Sbf1. Proc. Natl. Acad. Sci. USA 95: 9471-9476.
21. Fauman, E. B., and Saper, M. A. (1996). Structure and function of the protein tyrosine phosphatases. Trends Biochem. Sci. 21: 413-417.
22. Gottlieb, S., Driscoll, D. A., Punnett, H. H., Sellinger, B., Emanuel, B. S., and Budarf, M. L. (1998). Characterisation of 10p deletions suggests two non-overlapping regions contribute to the DiGeorge syndrome phenotype. Am. J. Med. Genet. 62: 495-498.
23. Gould, K. L., and Nurse, P. (1989). Tyrosine phosphorylation of the fission yeast cdc2+ protein kinase regulates entry into mitosis. Nature 342: 39-45.
24. Gu, W., Schneider, J. W., Condorelli, G., Kaushal, S., Mahdavi, V., and Nadal-Ginard, B. (1993). Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72: 309-324.
25. Guan, K. L., and Dixon, J. E. (1991). Evidence for protein-tyrosine-phosphatase catalysis proceeding via a cysteine-phosphate intermediate. J. Biol. Chem. 266: 17026-17030.
26. Hannon, G. J., Casso, D., and Beach, D. (1994). KAP: A dual specificity phosphatase that interacts with cyclin-dependent kinases. Proc. Natl. Acad. Sci. USA 91: 1731-1735.
27. Hanover, J. A. (1992). The nuclear pore: At the crossroads. FASEB J. 6: 2288-2295.
28. Hou, J. W., Wang, J. K., Tsai, W. Y., Chou, C. C., and Wang, T. R. (1997). CATCH 22: Deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects. J. Formos. Med. Assoc. 96: 419-423.
29. Hubbard, M. J., and Cohen, P. (1993). On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem. Sci. 18: 172-177.
30. Hunter, T. (1998). Anti-phosphatases take the stage. Nat. Genet. 18: 303-305.
31. Ichimura, K., Schmidt, E. E., Miyakawa, A., Goike, H. M., and Collins, V. P. (1998). Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer, 22(1): 9-15.
32. Ittmann, M. M. (1998). Chromosome 10 alterations in prostate adenocarcinoma. Oncol. Rep. 5(6): 1329-1335. [Review]
33. Jia, Z., Barford, D., Flint, A. J., and Tonks, N. K. (1995). Structural basis for phosphotyrosine peptide recognition by protein tyrosine phosphatase 1B. Science 268: 1754-1758.
34. Jiang, Z., Zacksenhaus, E., Gallie, B. L., and Phillips, R. A. (1997). The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14: 1789-1797.
35. Kalderon, D., Roberts, B. L., Richardson, W. D., and Smith, A. E. (1984a). A short amino acid sequence able to specify nuclear location. Cell 39: 499-509.
36. Kalderon, D., Richardson, W. D., Markham, A. F., and Smith, A. E. (1984b). Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 311: 33-38.
37. Krueger, N. X., and Saito, H. (1992). A human transmembrane protein-tyrosine-phosphatase, PTP zeta, is expressed in brain and has an N-terminal receptor domain homologous to carbonic anhydrases. Proc. Natl. Acad. Sci. USA 89: 7417-7421.
38. LaForgia, S., Morse, B., Levy, J., Barnea, G., Cannizzaro, L. A., Li, F., Nowell, P. C., Boghosian-Sell, L., Glick, J., Weston, A., et al. (1991). Receptor protein-tyrosine phosphatase gamma is a candidate tumor suppressor gene at human chromosome region 3p21. Proc. Natl. Acad. Sci. USA 88: 5036-5040.
39. Lan, M. S., Wasserfall, C., Maclaren, N. K., and Notkins, A. L. (1996). IA-2, a transmembrane protein of the protein tyrosine phosphatase family, is a major autoantigen in insulin-dependent diabetes mellitus. Proc. Natl. Acad. Sci. USA 93: 6367-6370.
40. Laporte, J., Hu, L. J., Kretz, C., Mandel, J. L., Kioschis, P., Coy, J. F., Klauck, S. M., Poustka, A., and Dahl, N. (1996). A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat. Genet. 13.
41. Li, D. M., and Sun, H. (1997). TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res. 57: 2124-2129.
42. Li, L., Ernsting, B. R., Wishart, M. J., Lohse, D. L., and Dixon, J. E. (1997). A family of putative tumor suppressors is structurally and functionally conserved in humans and yeast. J. Biol. Chem. 272: 29403-29406.
43. Martell, K. J., Angelotti, T., and Ullrich, A. (1998). The "VH1-like" Dual specificity protein tyrosine phosphatases. Mol. Cells. 8: 2-11.
44. Monden, T., Yamamoto, H., Ikeda, K., Izawa, H., Tsujie, M., Ohnishi, T., Miyoshi, Y., Sekimoto, M., Tomita, N., and Monden, M. (1996). RB gene expression in gastrointestinal tract. Nippon Rinsho. 54: 965-971.
45. Neel, B. G. (1993). Structure and function of SH2-domain containing tyrosine phosphatases. Semin. Cell Biol. 4: 419-432.
46. Nelen, M. R., van Staveren, W. C., Peeters, E. A., Hassel, M. B., Gorlin, R. J., Hamm, H., Lindboe, C. F., Fryns, J. P., Sijmons, R. H., Woods, D. G., Mariman, E. C., Padberg, G. W., and Kremer, H. (1997). Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum. Mol. Genet. 6: 1383-1387.
47. Nishizaki, T., Ozaki, S., Harad, K., Ito, H., Arai, H., Beppu, T., and Sasaki, K. (1998). Investigation of genetic alterations in associated with the grade of astrocytic tumor by comparative genomic hybridization. Genes Chromosomes Cancer 21(4): 340-346.
48. Nurse, P. (1990). Universal control mechanism regulating onset of M-phase. Nature 344: 503-508.
49. Olson, E. N., and Klein, W. H. (1994). bHLH factors in muscle development: Dead lines and commitments, what to leave in and what to leave out. Genes Dev. 8: 1-8.
50. Pot, D. A., and Dixon, J. E. (1992). Active site labeling of a receptor-like protein tyrosine phosphatase. J. Biol. Chem. 267: 140-143.
51. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467.
52. Sauter, G., Moch, H., Wagner, U., Bubendorf, L., Gasser, T. C., and Mihatsch, M. J. (1997). Genomic changes in urinary bladder cancer. Vert. Dtsch. Ges. Pathol. 287-296.
53. Schneider, J. W., Gu, W., Zhu, L., Mahdavi, V., and Nadal-Ginard, B. (1994). Reversal of terminal differentiation mediated by p107 in Rb-/- muscle cells. Science 264: 1467-1471.
54. Schuffenhauer, S., Lichtner, P., Peykar-Derakhshandeh, P., Murken, J., Hass, O. A., Back, E., Wolff, G., Zabel, B., Barisic, I., Rauch, A., Borochowitz, Z., Dallapiccola, B., Ross, M., and Metinger, T. (1998). Deletion mapping on chromosome 10p and definition of a critical region for the second DiGeorge syndrome locus (DGS2). Eur. J. Hum. Genet. 6: 213-225.
55. Sebastian, B., Kakizuka, A., and Hunter, T. (1993). Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. Natl. Acad. Sci. USA 90: 3521-3524.
56. Sellers, W. R., and Kaelin, W. G. (1997). Role of retinoblastoma protein in the pathogenesis of human cancer. J. Ciln. Oncol. 15: 3301-3312.
57. Shultz, L. D., Schweitzer, P. A., Rajan, T. V., Yi, T., Ihle, J. N., Matthews, R. J., Thomas, M. L., and Beier, D. R. (1993). Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73: 1445-1454.
58. Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D. H., and Tavtigian, S. V. (1997). Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet. 15.
59. Tsui, H. W., Siminovitch, K. A., de Souza, L., and Tsui, F. W. (1993). Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat. Genet. 4: 124-129.
60. Wera, S., and Hemmings, B. A. (1995). Serine/threonine protein phosphatases. Biochem. J. 311: 17-29.
61. Wishart, M. J., Denu, J. M., Williams, J. A., and Dixon, J. E. (1995). A single mutation converts a novel phosphotyrosine binding domain into a dual-specificity phosphatase. J. Biol. Chem. 270: 26782-26785.
62. Wishart, M. J., and Dixon, J. E. (1998). Gathering STYX: Phosphatase-like form predicts functions for unique protein-interaction domains. Trends Biochem. Sci. 23: 301-306.